DK388484A - Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel - Google Patents

Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel Download PDF

Info

Publication number
DK388484A
DK388484A DK388484A DK388484A DK388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A DK 388484 A DK388484 A DK 388484A
Authority
DK
Denmark
Prior art keywords
chromonalkaloid
medicine
isolated
dysoxylum binectariferum
binectariferum
Prior art date
Application number
DK388484A
Other languages
English (en)
Other versions
DK388484D0 (da
Inventor
Sujata Vasudev Bhat
Virbala Shah
Alihussein Nomanbha Dohadwalla
Sadashiv Shantaram Mandrekar
Noel John De Souza
Gerhard Dickneite
Roland Kurrle
Hans-Ulrich Schorlemmer
Hans-Harald Sedlacek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK388484D0 publication Critical patent/DK388484D0/da
Publication of DK388484A publication Critical patent/DK388484A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK388484A 1983-08-12 1984-08-10 Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel DK388484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833329186 DE3329186A1 (de) 1983-08-12 1983-08-12 Chromonalkaloid, verfahren zu seiner isolierung aus dysoxylum binectariferum, und seine verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
DK388484D0 DK388484D0 (da) 1984-08-10
DK388484A true DK388484A (da) 1985-02-13

Family

ID=6206424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK388484A DK388484A (da) 1983-08-12 1984-08-10 Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel

Country Status (6)

Country Link
US (1) US4603137A (da)
EP (1) EP0137193A3 (da)
JP (1) JPS6058977A (da)
DE (1) DE3329186A1 (da)
DK (1) DK388484A (da)
ZA (1) ZA846211B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (da) * 1986-04-11 1989-02-04 Hoechst India
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
EP0508347A1 (en) * 1991-04-10 1992-10-14 Hoechst Aktiengesellschaft 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl)) piperidinyl]-4H-1-benzopyran-4-one, its preparation and its use
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
AU767241B2 (en) * 1998-09-14 2003-11-06 Qiang Xu Immunosuppressive agents
DE10113513A1 (de) * 2001-03-20 2002-10-02 Medinnova Ges Med Innovationen Kombinationspräparat zur Prophylaxe und/oder Therapie von Nervenzell- und/oder Gliazellschäden durch ein neues Behandlungsverfahren
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
BRPI0402875A (pt) 2004-07-21 2006-03-07 Fundacao Oswaldo Cruz composições medicamentosas à base de extrato de carapa guianensis e/ou dos compostos quìmicos isolados desse extrato
JP2008255008A (ja) * 2005-07-19 2008-10-23 Tokyo Medical & Dental Univ 滑膜細胞増殖抑制剤
WO2012012737A2 (en) 2010-07-23 2012-01-26 The University Of Toledo Stable tregs and related materials and methods
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー， インコーポレイテッド Ｍｃｌ－１阻害剤アルボシジブを用いた、ｂｃｌ－２阻害剤に対して非感受性である癌の治療レジメン
EP3890749A4 (en) 2018-12-04 2022-08-03 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS CANCER TREATMENT AGENT
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB882537A (en) * 1958-09-12 1961-11-15 Recordati Lab Farmacologico S Chromones and processes for the preparation thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives

Also Published As

Publication number Publication date
ZA846211B (en) 1985-03-27
EP0137193A3 (de) 1987-02-04
EP0137193A2 (de) 1985-04-17
US4603137A (en) 1986-07-29
DE3329186A1 (de) 1985-02-21
DK388484D0 (da) 1984-08-10
JPS6058977A (ja) 1985-04-05

Similar Documents

Publication Publication Date Title
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
DK158891C (da) Zeolitter, fremgangsmaade til fremstilling heraf samt anvendelse heraf
DK160052C (da) Chlorsubstituerede disaccharider og fremgangsmaader til fremstilling deraf samt praeparater indeholdende sacchariderne som soedemidler
IT8420470V0 (it) Gambo per endoprotesi.
KR860004880A (ko) N-[아미노카보닐]-3-트리플루오로메틸피리딘-2-설폰아미드의 제조방법
DK163984C (da) Dampmodificeret krystallinsk galloaluminosilicat, fremgangsmaade til dets fremstilling samt dets anvendelse
DK49283A (da) Pyrazoloxaziner, -thiaziner og -quinoliner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK388484A (da) Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel
IT8419789A0 (it) Chiusura per bottiglie.
NO166473C (no) Stabilisert loesning av et isotiazolon samt anvendelse derav som biocid og konserveringsmiddel, og anvendelse av et hydroksyloesningsmiddel til stabilisering av en isotiazolonloesning.
DK479284D0 (da) Pyrazolderivat og dets anvendelse som herbicid
FI864267A (fi) Modifierad process foer satsvis rening av sio2 i naerliggande fraktioner.
DK98182A (da) Fungicidt praeparat,fremgangsmaade til dets fremstilling samt anvendelse deraf
DK246984A (da) Dihydrobenzopyrrolobenzodiazepiner en fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
FI842818A0 (fi) Anvaendningsanordning foer aerosol.
BR8200926A (pt) Cabeco de fraturas
DK342182A (da) Dispergeringsmiddel, fremgangsmaade til fremstilling heraf samt dets anvendelse
FI885952A (fi) Ergonomisk sprayapparat eller foerdelningsanordning foer aerosol.
DK179784D0 (da) Krystallinsk zinksilicat, fremgangsmade til dets fremstilling samt dets anvendelse
DK382283A (da) Thiazol-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
DK402685D0 (da) Alfa-glucosidaseinhibitor, dets fremstilling og anvendelse samt farmaceutiske praeparater
NO162962C (no) Diaminoalkoholer og anvendelse derav som midler for fjernelse av sure gasser.
DK177281A (da) Monohydratiseret isophtalsyrepicolylamid fremgangsmaade til dets fremstilling samt dets anvendelse
FI860597A0 (fi) Foerfarande foer framstaellning av en substituerad fenylurea.
DK247884A (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider, fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen

Legal Events

Date Code Title Description
ATS Application withdrawn